Atara Biotherapeutics Announces Presentations Highlighting Tab-cel and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting Nasdaq:ATRA

Press/Media: Press / Media

PeriodMay 15 2019

Media coverage

1

Media coverage

  • TitleAtara Biotherapeutics Announces Presentations Highlighting Tab-cel and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting Nasdaq:ATRA
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    CountryJordan
    Date5/15/19
    PersonsMissak Haigentz